Good Response to COVID-19 Vaccine After HSCT and CAR T-cell Tx Good Response to COVID-19 Vaccine After HSCT and CAR T-cell Tx
A small study shows relatively good responses among patients with blood cancers who underwent allogeneic hematopoeitic stem cells transplant (HSCT) and CAR T-cell therapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | COVID-19 | Hematology | Stem Cell Therapy | Stem Cells | Study | Transplants | Vaccines